Conatumumab: a novel monoclonal antibody against death receptor 5 for the treatment of advanced malignancies in adults

Author: Bajaj Madhuri   Heath Elisabeth I  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.11, Iss.11, 2011-11, pp. : 1519-1524

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content